<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39309499</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2211-3835</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta pharmaceutica Sinica. B</Title><ISOAbbreviation>Acta Pharm Sin B</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.</ArticleTitle><Pagination><StartPage>4164</StartPage><EndPage>4173</EndPage><MedlinePgn>4164-4173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.apsb.2024.05.018</ELocationID><Abstract><AbstractText>Viruses often manipulate ubiquitination pathways to facilitate their replication and pathogenesis. CUL2<sup>ZYG11B</sup> known as the substrate receptor of cullin-2 RING E3 ligase, is bound by SARS-CoV-2 ORF10 to increase its E3 ligase activity, leading to degradation of IFT46, a protein component of the intraflagellar transport (IFT) complex B. This results in dysfunctional cilia, which explains certain symptoms that are specific to COVID-19. However, the precise molecular mechanism of how ORF10 recognizes CUL2<sup>ZYG11B</sup> remains unknown. Here, we determined the crystal structure of CUL2<sup>ZYG11B</sup> complexed with the N-terminal extension (NTE) of SARS-CoV-2 ORF10 (2.9 Å). The structure reveals that the ORF10 N-terminal heptapeptide (NTH) mimics the Gly/N-degron to bind CUL2<sup>ZYG11B</sup>. Mutagenesis studies identified key residues within ORF10 that are key players in its interaction with CUL2<sup>ZYG11B</sup> both in ITC assay and <i>in vivo</i> cells. In addition, we prove that enhancement of CUL2<sup>ZYG11B</sup> activity for IFT46 degradation by which ORF10-mediated correlates with the binding affinity between ORF10 and CUL2<sup>ZYG11B</sup>. Finally, we used a Global Protein Stability system to show that the NTH of ORF10 mimics the Gly/N-degron motif, thereby binding competitively to CUL2<sup>ZYG11B</sup> and inhibiting the degradation of target substrates bearing the Gly/N-degron motif. Overall, this study sheds light on how SARS-CoV-2 ORF10 exploits the ubiquitination machinery for proteasomal degradation, and offers valuable insights for optimizing PROTAC-based drug design based on NTH CUL2<sup>ZYG11B</sup> interaction, while pinpointing a promising target for the development of treatments for COVID-19.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Kaixiang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University General Hospital, Department of Immunology, Tianjin Medical University, Tianjin 300070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Linyue</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, Yan'an University, Shaanxi Province, Yan'an 716000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Ziyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tongyun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing, Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shuofeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing, Faculty of Medicine, the University of Hong Kong, Pokfulam, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiaopan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi</LastName><ForeName>Wenyi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University General Hospital, Department of Immunology, Tianjin Medical University, Tianjin 300070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Acta Pharm Sin B</MedlineTA><NlmUniqueID>101600560</NlmUniqueID><ISSNLinking>2211-3835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crystal structure</Keyword><Keyword MajorTopicYN="N">Drug design</Keyword><Keyword MajorTopicYN="N">ORF10</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cullin-2 RING E3 ligase</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39309499</ArticleId><ArticleId IdType="pmc">PMC11413682</ArticleId><ArticleId IdType="doi">10.1016/j.apsb.2024.05.018</ArticleId><ArticleId IdType="pii">S2211-3835(24)00196-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Makaronidis J., Mok J., Balogun N., Magee C.G., Omar R.Z., Carnemolla A., et al. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: an observational cohort study. PLoS Med. 2020;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529306</ArticleId><ArticleId IdType="pubmed">33001967</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan H., Chen C., Chen H., Hong H., Huang Y., Ling K., et al. TALPID3 and ANKRD26 selectively orchestrate FBF1 localization and cilia gating. Nat Commun. 2020;11:2196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198521</ArticleId><ArticleId IdType="pubmed">32366837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y.J., Okuda K., Edwards C.E., Martinez D.R., Asakura T., Dinnon K.H., 3rd, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182:429. 46.e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Wang W., Liu Z., Liang C., Wang W., Ye F., et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020;11:3910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413383</ArticleId><ArticleId IdType="pubmed">32764693</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinot R., Hubert M., de Melo G.D., Lazarini F., Bruel T., Smith N., et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat Commun. 2021;12:4354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285531</ArticleId><ArticleId IdType="pubmed">34272374</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Li M., Ou G. COVID-19, cilia, and smell. FEBS J. 2020;287:3672–3676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426555</ArticleId><ArticleId IdType="pubmed">32692465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Liu C., Yang B., Zhang H., Jiao J., Zhang R., et al. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity. J Cell Biol. 2022;221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9184850</ArticleId><ArticleId IdType="pubmed">35674692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca B.F., Chakrabarti L.A. A close shave: how SARS-CoV-2 induces the loss of cilia. J Cell Biol. 2022;221</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198720</ArticleId><ArticleId IdType="pubmed">35695891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel C.J., Mayer C., Poch O., Thompson J.D. Characterization of accessory genes in coronavirus genomes. Virol J. 2020;17:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450977</ArticleId><ArticleId IdType="pubmed">32854725</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagliani R., Forni D., Clerici M., Sironi M. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses. Infect Genet Evol. 2020;83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199688</ArticleId><ArticleId IdType="pubmed">32387562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459–468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena E.L., Donahue C.J., Vaites L.P., Li J., Rona G., O'Leary C., et al. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021;118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092598</ArticleId><ArticleId IdType="pubmed">33827988</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Hou P., Ma W., Wang X., Wang H., Yu Z., et al. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol. 2022;19:67–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi M. ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion. Nat Rev Immunol. 2022;22:331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970066</ArticleId><ArticleId IdType="pubmed">35361899</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zheng Y., Deng J., Nan M.L., Xiao Y., Zhuang M.W., et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Virol. 2022;94:5174–5188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes M.F., Chan J.Z., Hung C.C.J., Tomczewski M.V., Duncan R.E. Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein. Life Sci. 2022;301</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9091075</ArticleId><ArticleId IdType="pubmed">35568225</ArticleId></ArticleIdList></Reference><Reference><Citation>Timms R.T., Zhang Z., Rhee D.Y., Harper J.W., Koren I., Elledge S.J. A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation. Science. 2019;365</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090375</ArticleId><ArticleId IdType="pubmed">31273098</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldeeb M., Esmaili M., Fahlman R. Degradation of proteins with N-terminal glycine. Nat Struct Mol Biol. 2019;26:761–763.</Citation><ArticleIdList><ArticleId IdType="pubmed">31477902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H., Jan Fada B. Specificity in ubiquitination triggered by virus infection. Int J Mol Sci. 2020;21:4088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313089</ArticleId><ArticleId IdType="pubmed">32521668</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503–533.</Citation><ArticleIdList><ArticleId IdType="pubmed">11395416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X., Li Y., Wang G., Zhou Z., Song G., Feng Q., et al. Molecular basis for recognition of Gly/N-degrons by CRL2(ZYG11B) and CRL2(ZER1) Mol Cell. 2021;81 3262–74.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">34214466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw R.A., Brickey W.W., Walker K.W. N-terminal processing: the methionine aminopeptidase and N alpha-acetyl transferase families. Trends Biochem Sci. 1998;23:263–267.</Citation><ArticleIdList><ArticleId IdType="pubmed">9697417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Zhu K., Wojdyla J.A., Chen P., Qin B., Li Z., et al. Crystal structure of the NS3-like helicase from Alongshan virus. IUCrJ. 2020;7:375–382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201283</ArticleId><ArticleId IdType="pubmed">32431821</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Qin B., Chen P., Zhu K., Hou P., Wojdyla J.A., et al. Crystal structure of SARS-CoV-2 papain-like protease. Acta Pharma Sin B. 2021;11:237–245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467110</ArticleId><ArticleId IdType="pubmed">32895623</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr. 2010;66:125–132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815665</ArticleId><ArticleId IdType="pubmed">20124692</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011;67:235–242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069738</ArticleId><ArticleId IdType="pubmed">21460441</ArticleId></ArticleIdList></Reference><Reference><Citation>Echols N., Grosse-Kunstleve R.W., Afonine P.V., Bunkoczi G., Chen V.B., Headd J.J., et al. Graphical tools for macromolecular crystallography in PHENIX. J Appl Crystallogr. 2012;45:581–586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3359726</ArticleId><ArticleId IdType="pubmed">22675231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Mu Z., Yu X., Qin B., Wojdyla J., Wang M., et al. Structural insight into conformational changes induced by ATP binding in a type III secretion-associated ATPase from Shigella flexneri. Front Microbiol. 2018;9:1468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6036117</ArticleId><ArticleId IdType="pubmed">30013545</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Mu Z., Qin B., Sun Y., Cui S. Structure-based prototype peptides targeting the Pseudomonas aeruginosa Type VI secretion system effector as a novel antibacterial strategy. Front Cell Infect Microbiol. 2017;7:411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5611513</ArticleId><ArticleId IdType="pubmed">28979890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Zhu K., Qin B., Olieric V., Wang M., Cui S. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions. Nat Commun. 2021;12:2843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121815</ArticleId><ArticleId IdType="pubmed">33990585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Tian H., Zhu K., Li Q., Hao W., Wang L., et al. Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport. Nat Commun. 2022;13:4782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9376891</ArticleId><ArticleId IdType="pubmed">35970938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhao Y., Yan X., Ye C., Weirich S., Zhang B., et al. CRL2(ZER1/ZYG11B) recognizes small N-terminal residues for degradation. Nat Commun. 2022;13:7636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741652</ArticleId><ArticleId IdType="pubmed">36496439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjana N.E., Shalem O., Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783–784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486245</ArticleId><ArticleId IdType="pubmed">25075903</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>